Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

March 21, 2025 00:26:13

Show Notes

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.  

Dr Rena Callahan and Dr Roberto Salgado discuss key biomarkers, testing methods, and clinical decision-making, offering expert insights on how to optimise precision medicine.  

Topics include liquid vs. tumour biopsy, single gene vs. broad panel testing, and regional differences in testing practices.  

Tune in for a practical, expert-led discussion on how molecular testing can guide personalised treatment and improve patient outcomes. 

 

Key clinical takeaways: 

 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/precision-oncology-connect/programmes/molecular-testing-targeted-therapy-metastatic-breast-cancer/?media=0

Or watch on YouTube: https://www.youtube.com/watch?v=CTnXmh1oDwQ

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/ntrk-connect/  

X: https://x.com/PresOnc_Connect  

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Thermo Fisher Scientific. 

This podcast is developed by cor2ed.com 

Published March 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

March 28, 2024 00:23:40
Episode Cover

mCRC: Optimising patient outcomes with late-line treatment

What treatment options are available for patients with metastatic colorectal cancer who have already progressed through multiple lines of therapy?  How can we select...

Listen

Episode

November 08, 2024 00:25:47
Episode Cover

BRAF-mutated CRC: testing to treatment

Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available...

Listen

Episode

January 25, 2024 00:27:48
Episode Cover

Lung cancer: Pre-analytical phase challenges and biomarker testing

What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations?...

Listen